Payment Forms for Paystack Plugin up to 3.4.1 on WordPress Shortcode cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.1 | $0-$5k | 0.00 |
Summary
A vulnerability classified as problematic has been found in Payment Forms for Paystack Plugin up to 3.4.1 on WordPress. Affected by this issue is some unknown functionality of the component Shortcode Handler. The manipulation leads to cross site scripting. This vulnerability is listed as CVE-2023-5665. The attack may be initiated remotely. There is no available exploit.
Details
A vulnerability was found in Payment Forms for Paystack Plugin up to 3.4.1 on WordPress (WordPress Plugin). It has been rated as problematic. This issue affects some unknown processing of the component Shortcode Handler. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
The Payment Forms for Paystack plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the plugin's shortcodes in all versions up to, and including, 3.4.1 due to insufficient input sanitization and output escaping on user supplied attributes. This makes it possible for authenticated attackers with contributor-level and above permissions to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page. CVE-2024-32130 is likely a duplicate of this issue.
The weakness was presented 02/07/2024. The advisory is shared at wordfence.com. The identification of this vulnerability is CVE-2023-5665 since 10/19/2023. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.1VulDB Meta Temp Score: 5.1
VulDB Base Score: 3.5
VulDB Temp Score: 3.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔍
CNA Base Score: 6.4
CNA Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
10/19/2023 🔍02/07/2024 🔍
02/07/2024 🔍
04/12/2026 🔍
Sources
Advisory: wordfence.comStatus: Not defined
CVE: CVE-2023-5665 (🔍)
GCVE (CVE): GCVE-0-2023-5665
GCVE (VulDB): GCVE-100-253133
Entry
Created: 02/07/2024 18:29Updated: 04/12/2026 03:37
Changes: 02/07/2024 18:29 (38), 03/01/2024 23:18 (1), 08/12/2024 16:20 (36), 04/20/2025 03:45 (3), 04/12/2026 03:37 (1)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.